BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 11121425)

  • 1. A molecular link between the common phenotypes of type 1 glycogen storage disease and HNF1alpha-null mice.
    Hiraiwa H; Pan CJ; Lin B; Akiyama TE; Gonzalez FJ; Chou JY
    J Biol Chem; 2001 Mar; 276(11):7963-7. PubMed ID: 11121425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The molecular basis of type 1 glycogen storage diseases.
    Chou JY
    Curr Mol Med; 2001 Mar; 1(1):25-44. PubMed ID: 11899241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of hepatocellular adenoma and correction of metabolic abnormalities in murine glycogen storage disease type Ia by gene therapy.
    Lee YM; Jun HS; Pan CJ; Lin SR; Wilson LH; Mansfield BC; Chou JY
    Hepatology; 2012 Nov; 56(5):1719-29. PubMed ID: 22422504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type I glycogen storage diseases: disorders of the glucose-6-phosphatase/glucose-6-phosphate transporter complexes.
    Chou JY; Jun HS; Mansfield BC
    J Inherit Metab Dis; 2015 May; 38(3):511-9. PubMed ID: 25288127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type I glycogen storage diseases: disorders of the glucose-6-phosphatase complex.
    Chou JY; Matern D; Mansfield BC; Chen YT
    Curr Mol Med; 2002 Mar; 2(2):121-43. PubMed ID: 11949931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycogen storage disease type I and G6Pase-β deficiency: etiology and therapy.
    Chou JY; Jun HS; Mansfield BC
    Nat Rev Endocrinol; 2010 Dec; 6(12):676-88. PubMed ID: 20975743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular genetics of type 1 glycogen storage disease.
    Janecke AR; Mayatepek E; Utermann G
    Mol Genet Metab; 2001 Jun; 73(2):117-25. PubMed ID: 11386847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular biology and gene therapy for glycogen storage disease type Ib.
    Chou JY; Cho JH; Kim GY; Mansfield BC
    J Inherit Metab Dis; 2018 Nov; 41(6):1007-1014. PubMed ID: 29663270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type-1c glycogen storage disease is not caused by mutations in the glucose-6-phosphate transporter gene.
    Lin B; Hiraiwa H; Pan CJ; Nordlie RC; Chou JY
    Hum Genet; 1999 Nov; 105(5):515-7. PubMed ID: 10598822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucocorticoids activate transcription of the gene for the glucose-6-phosphate transporter, deficient in glycogen storage disease type 1b.
    Hiraiwa H; Chou JY
    DNA Cell Biol; 2001 Aug; 20(8):447-53. PubMed ID: 11560776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocyte nuclear factor 1alpha is an accessory factor required for activation of glucose-6-phosphatase gene transcription by glucocorticoids.
    Lin B; Morris DW; Chou JY
    DNA Cell Biol; 1998 Nov; 17(11):967-74. PubMed ID: 9839806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The SLC37 family of phosphate-linked sugar phosphate antiporters.
    Chou JY; Sik Jun H; Mansfield BC
    Mol Aspects Med; 2013; 34(2-3):601-11. PubMed ID: 23506893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutropenia in type Ib glycogen storage disease.
    Chou JY; Jun HS; Mansfield BC
    Curr Opin Hematol; 2010 Jan; 17(1):36-42. PubMed ID: 19741523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The glucose-6-phosphate transporter is a phosphate-linked antiporter deficient in glycogen storage disease type Ib and Ic.
    Chen SY; Pan CJ; Nandigama K; Mansfield BC; Ambudkar SV; Chou JY
    FASEB J; 2008 Jul; 22(7):2206-13. PubMed ID: 18337460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New insights into the organisation and intracellular localisation of the two subunits of glucose-6-phosphatase.
    Soty M; Chilloux J; Casteras S; Grichine A; Mithieux G; Gautier-Stein A
    Biochimie; 2012 Mar; 94(3):695-703. PubMed ID: 21983240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of HNF1alpha, HNF3gamma, and cyclic AMP in glucose-6-phosphatase gene activation.
    Lin B; Morris DW; Chou JY
    Biochemistry; 1997 Nov; 36(46):14096-106. PubMed ID: 9369482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver-directed gene therapy for murine glycogen storage disease type Ib.
    Kwon JH; Lee YM; Cho JH; Kim GY; Anduaga J; Starost MF; Mansfield BC; Chou JY
    Hum Mol Genet; 2017 Nov; 26(22):4395-4405. PubMed ID: 28973635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of the liver fatty acid-binding protein gene by hepatocyte nuclear factor 1alpha (HNF1alpha). Alterations in fatty acid homeostasis in HNF1alpha-deficient mice.
    Akiyama TE; Ward JM; Gonzalez FJ
    J Biol Chem; 2000 Sep; 275(35):27117-22. PubMed ID: 10852923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-function analysis of the glucose-6-phosphate transporter deficient in glycogen storage disease type Ib.
    Chen LY; Pan CJ; Shieh JJ; Chou JY
    Hum Mol Genet; 2002 Dec; 11(25):3199-207. PubMed ID: 12444104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutrophil stress and apoptosis underlie myeloid dysfunction in glycogen storage disease type Ib.
    Kim SY; Jun HS; Mead PA; Mansfield BC; Chou JY
    Blood; 2008 Jun; 111(12):5704-11. PubMed ID: 18420828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.